Ibnsina Pharma (EGX:ISPH)
Egypt · Delayed Price · Currency is EGP 10.67
+0.07 (0.66%)
At close: Oct 20, 2026
Ibnsina Pharma Revenue
Ibnsina Pharma had revenue of 20.99B EGP in the quarter ending June 30, 2026, with 16.62% growth. This brings the company's total for the last twelve months to 83.04B, up 21.99% year-over-year. In the year 2025, Ibnsina Pharma had annual revenue of 76.60B with 37.17% growth. That makes Ibnsina Pharma the 5,893rd largest company in the world by revenue and 6th in Egypt.
Revenue (ttm)
83.04B
Revenue Growth
+21.99%
P/S Ratio
0.13
Revenue / Employee
15.10M
Employees
5,500
Market Cap
10.76B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 76.60B | 20.75B | 37.17% |
| Dec 31, 2024 | 55.84B | 21.89B | 64.49% |
| Dec 31, 2023 | 33.95B | 11.68B | 52.48% |
| Dec 31, 2022 | 22.26B | 531.66M | 2.45% |
| Dec 31, 2021 | 21.73B | 3.05B | 16.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.